Related Experiment Video
Updated: Oct 9, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Profile of Children With Tuberculosis in a Pediatric Intensive Care Unit in Mumbai
Soumya Renji1, Rekha Solomon2, Deepali Wankhade1
1Department of Pediatrics, PD Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra.
Insights
Neurotuberculosis was the primary reason for pediatric intensive care unit admissions. Early diagnosis and drug sensitivity testing are crucial for critically ill children with tuberculosis (TB).
Area of Science:
- Pediatric critical care medicine
- Infectious diseases
- Mycobacteriology
Background:
- Tuberculosis (TB) remains a significant global health challenge, particularly in pediatric populations.
- Critically ill children with TB often present complex clinical scenarios requiring intensive care management.
- Understanding the profile of pediatric TB patients in intensive care settings is essential for improving outcomes.
Purpose of the Study:
- To analyze the clinical characteristics and outcomes of confirmed pediatric tuberculosis patients admitted to a pediatric intensive care unit (PICU).
- To identify the main indications for PICU admission in this patient group.
- To assess the prevalence of drug resistance among pediatric TB cases in an intensive care setting.
Main Methods:
- Retrospective analysis of bacteriologically proven pediatric TB cases admitted to a PICU between January 2007 and December 2019.
- Data collection included patient demographics, reasons for admission, clinical findings, and microbiological results.
- Drug resistance was classified according to World Health Organization definitions.
Main Results:
- Fifty-nine children were included, with neurotuberculosis being the most common reason for PICU admission (31 children).
- Severe respiratory failure and ARDS were observed in some cases.
- Drug sensitivity testing revealed significant rates of multidrug-resistant, pre-extreme drug-resistant, and extreme drug-resistant tuberculosis.
Conclusions:
- Neurotuberculosis is a leading cause of PICU admission for pediatric TB patients.
- Emphasis should be placed on obtaining microbiological samples for culture and drug sensitivity testing in critically ill children with suspected or confirmed TB.
- Improved diagnostic strategies are needed for early detection and management of drug-resistant TB in children.
Objective:
This study was done to analyze the profile of confirmed pediatric TB patients seen in an intensive care setting.
Methods:
Data of all children admitted in our PICU with bacteriologically proven tuberculosis (smear, culture, poly-merase chain reaction, genotypic testing or Pyrosequencing) between January, 2007 and December, 2019 were retrieved. Drug resistance was classified as per World Health Organization definitions.
Results:
59 children (28 boys) met the inclusion criteria (median (IQR) age 8 (4,13) years). About a third (22/59) had past history of treatment with antituberculosis drugs. The indications for admission to PICU were monitoring and management of neurological status in 31 children, post procedure monitoring in 20 children and respiratory failure in 8 children. Severe ARDS was seen in 2 children. Out of 37 children with neuro-tuberculosis, 19 children had TB in additional sites, and 9 children died. Sample positivity rate for CSF culture was 66%. Drug sensitivity testing (DST) of positive culture was done in 35 cases and showed multidrug resistance in 4 children, pre-XDR (extreme drug resistance) in 10 and XDR in 5 children.
Conclusion:
Neurotuberculosis was the commonest reason for admission to PICU. Concerted efforts should be made to obtain samples for culture and drug sensitivity testing in critically ill children with tuberculosis.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pneumonia III: Complications and Assessment

